West Pharmaceutical Company Insiders

WST Stock  USD 336.34  0.86  0.26%   
West Pharmaceutical's insiders are aggressively selling. The analysis of insiders' sentiment of trading West Pharmaceutical Services stock suggests that vertually all insiders are panicking at this time. West Pharmaceutical employs about 10.6 K people. The company is managed by 34 executives with a total tenure of roughly 212 years, averaging almost 6.0 years of service per executive, having 311.76 employees per reported executive.
Eric Green  CEO
President, Chief Executive Officer, Director
Patrick Zenner  Chairman
Independent Chairman of the Board

West Pharmaceutical's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-08Jared MoskowitzDisposed @ 323.9
2024-10-29Charles WitherspoonDisposed 703 @ 310.4View
2024-08-19Charles WitherspoonDisposed 1029 @ 300View
2024-06-12Silji AbrahamDisposed 1800 @ 330.78View
2024-05-10Thomas W HofmannDisposed 617 @ 365.92View
2024-05-07Eric Mark GreenDisposed 66000 @ 366.65View
2024-03-11Chad WintersDisposed 815 @ 358.82View
2024-02-28Charles WitherspoonDisposed 2019 @ 358.62View
2024-02-27Eric Mark GreenDisposed 64132 @ 359.85View
2024-02-23Silji AbrahamDisposed 7012 @ 365View
Monitoring West Pharmaceutical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

West Pharmaceutical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with West Pharmaceutical's future performance. Based on our forecasts, it is anticipated that West will maintain a workforce of slightly above 10600 employees by February 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

West Pharmaceutical's latest congressional trading

Congressional trading in companies like West Pharmaceutical, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in West Pharmaceutical by those in governmental positions are based on the same information available to the general public.
2024-12-09Representative Jared MoskowitzAcquired Under $15KVerify
2024-10-08Representative Ro KhannaAcquired Under $15KVerify
2024-08-21Representative Jared MoskowitzAcquired Under $15KVerify
2020-10-19Representative Greg GianforteAcquired $50K to $100KVerify

West Pharmaceutical Management Team Effectiveness

The company has Return on Asset of 0.1 % which means that on every $100 spent on assets, it made $0.1 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1778 %, implying that it generated $0.1778 on every 100 dollars invested. West Pharmaceutical's management efficiency ratios could be used to measure how well West Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, West Pharmaceutical's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.15 in 2025, whereas Return On Capital Employed is likely to drop 0.10 in 2025. At this time, West Pharmaceutical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4.6 B in 2025, whereas Non Current Liabilities Total is likely to drop slightly above 307.8 M in 2025.
Net Income Applicable To Common Shares is likely to gain to about 707.5 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 74.7 M in 2025.

West Pharmaceutical Workforce Comparison

West Pharmaceutical Services is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 230,680. West Pharmaceutical holds roughly 10,600 in number of employees claiming about 5% of equities under Health Care industry.

West Pharmaceutical Profit Margins

The company has Net Profit Margin of 0.17 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.260.34
Way Down
Slightly volatile
Net Profit Margin0.190.18
Notably Up
Slightly volatile
Operating Profit Margin0.220.21
Sufficiently Up
Slightly volatile
Pretax Profit Margin0.220.21
Sufficiently Up
Slightly volatile
Return On Assets0.150.14
Notably Up
Slightly volatile
Return On Equity0.0960.19
Way Down
Slightly volatile

West Pharmaceutical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific West Pharmaceutical insiders, such as employees or executives, is commonly permitted as long as it does not rely on West Pharmaceutical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, West Pharmaceutical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.6
3
5
 1,360 
 1,819 
2024-09-01
0.5
3
6
 37,261 
 69,022 
2024-06-01
1.75
14
8
 80,640 
 134,101 
2024-03-01
2.4444
22
9
 140,246 
 156,816 
2023-12-01
0.5
6
12
 2,784 
 16,384 
2023-09-01
0.4286
15
35
 108,752 
 211,504 
2023-06-01
0.7895
15
19
 79,064 
 141,030 
2023-03-01
2.2222
20
9
 131,867 
 99,436 
2022-12-01
0.25
2
8
 50,096 
 94,047 
2022-09-01
0.6667
2
3
 545.00 
 6,474 
2022-06-01
6.0
12
2
 7,180 
 956.00 
2022-03-01
1.2941
22
17
 103,073 
 22,952 
2021-12-01
1.0
2
2
 96.00 
 2,407 
2021-09-01
0.625
5
8
 10,061 
 31,481 
2021-06-01
2.5
10
4
 5,469 
 3,581 
2021-03-01
2.2857
16
7
 109,713 
 9,382 
2020-12-01
0.5714
4
7
 11,542 
 20,703 
2020-09-01
0.4444
4
9
 19,286 
 36,931 
2020-06-01
0.9412
16
17
 26,017 
 37,065 
2020-03-01
2.8333
17
6
 118,350 
 6,313 
2019-12-01
0.3333
1
3
 150.00 
 8,415 
2019-09-01
0.5
1
2
 159.00 
 67.00 
2019-06-01
4.0
12
3
 19,217 
 9,626 
2019-03-01
5.75
23
4
 184,407 
 9,289 
2018-09-01
1.5
6
4
 21,083 
 40,916 
2018-06-01
2.5
20
8
 176,294 
 242,687 
2018-03-01
22.0
22
1
 216,874 
 5,576 
2017-12-01
5.0
20
4
 1,756 
 24,610 
2017-06-01
3.8
19
5
 77,587 
 118,240 
2017-03-01
12.0
24
2
 200,971 
 8,758 
2016-12-01
7.5
30
4
 1,794 
 5,796 
2016-09-01
9.5
19
2
 14,765 
 17,623 
2016-06-01
5.6667
17
3
 23,874 
 10,366 
2016-03-01
1.4333
43
30
 463,061 
 173,744 
2015-12-01
2.4167
29
12
 104,289 
 106,572 
2015-09-01
1.3333
4
3
 53,414 
 109,356 
2015-06-01
2.0
26
13
 682,270 
 72,364 
2015-03-01
1.3636
45
33
 423,519 
 221,354 
2014-12-01
1.2222
22
18
 40,258 
 125,812 
2014-09-01
0.76
19
25
 109,206 
 232,432 
2014-06-01
5.0
20
4
 53,932 
 49,656 
2014-03-01
1.9545
43
22
 497,195 
 156,016 
2013-12-01
1.0769
28
26
 102,225 
 277,685 
2013-09-01
1.0
22
22
 49,808 
 122,991 
2013-06-01
1.1905
25
21
 241,689 
 425,565 
2013-03-01
2.2273
49
22
 452,805 
 75,323 
2012-12-01
1.2174
28
23
 253,939 
 457,492 
2012-09-01
5.5
11
2
 18,177 
 1,500 
2012-06-01
1.375
11
8
 170,724 
 268,009 
2012-03-01
3.0
21
7
 272,287 
 9,500 
2011-09-01
2.5
10
4
 4,237 
 9,290 
2011-06-01
1.5385
20
13
 169,351 
 266,330 
2011-03-01
2.875
23
8
 371,451 
 207,927 
2010-09-01
3.6667
11
3
 8,537 
 11,200 
2010-06-01
2.75
11
4
 20,284 
 7,438 
2010-03-01
1.5714
22
14
 366,942 
 136,394 
2009-12-01
1.4286
10
7
 31,601 
 52,231 
2009-09-01
0.4091
9
22
 84,599 
 156,709 
2009-06-01
3.3333
10
3
 21,473 
 15,380 
2009-03-01
2.6429
37
14
 287,331 
 50,012 
2008-12-01
4.8
24
5
 1,423 
 2,829 
2008-09-01
1.7333
26
15
 50,472 
 61,313 
2008-06-01
1.7368
33
19
 28,457 
 56,254 
2008-03-01
4.0
48
12
 315,005 
 136,096 
2007-12-01
5.6
28
5
 3,668 
 11,000 
2005-09-01
3.5
7
2
 6,074 
 8,601 
2005-06-01
7.0
7
1
 2,076 
 2,000 

West Pharmaceutical Notable Stakeholders

A West Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as West Pharmaceutical often face trade-offs trying to please all of them. West Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting West Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eric GreenPresident, Chief Executive Officer, DirectorProfile
Patrick ZennerIndependent Chairman of the BoardProfile
Bernard BirkettChief Financial Officer, Senior Vice President, Principal Accounting Officer, TreasurerProfile
Aileen RuffPatryPresident ManufacturingProfile
Don OCallaghanPresident DevicesProfile
Annette FavoriteChief Human Resource Officer, Senior Vice PresidentProfile
Silji AbrahamSenior Vice President and Chief Digital and Transformation OfficerProfile
David MontecalvoSenior Vice President, Chief Operating and Supply Chain OfficerProfile
Christopher RyanSenior Vice President of Commercial Products and Emerging MarketsProfile
Quintin LaiVice President - Corporate Development, Strategy and Investor RelationsProfile
Andy PolywaczPresident SystemsProfile
George MillerSenior Vice President General Counsel, Corporate SecretaryProfile
Chad WintersChief Accounting Officer, Principal Accounting Officer, Vice President, Corporate ControllerProfile
Eric ResnickChief Technology Officer, Vice PresidentProfile
Mark ButhmanIndependent DirectorProfile
Deborah TannerIndependent DirectorProfile
William FeeheryIndependent DirectorProfile
Robert FrielIndependent DirectorProfile
Myla LaiGoldmanIndependent DirectorProfile
Paula JohnsonIndependent DirectorProfile
Douglas MichelsIndependent DirectorProfile
Paolo PucciIndependent DirectorProfile
Thomas HofmannIndependent DirectorProfile
Charles CPAVP TreasurerProfile
John CFAHead RelationsProfile
Rudy PoussotSenior DevelopmentProfile
Kathy DePaduaSenior OfficerProfile
Dr CFAVice RelationsProfile
Richard LuzziVP HRProfile
Michele PolinskyVice CommunicationsProfile
Kimberly MacKaySenior Vice President General Counsel, Corporate SecretaryProfile
Molly JosephDirectorProfile
Cindy ReissClarkSenior Vice President of Global Market Units and Commercial SolutionsProfile
Robert SeguraVP DevelProfile

About West Pharmaceutical Management Performance

The success or failure of an entity such as West Pharmaceutical often depends on how effective the management is. West Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of West management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the West management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.14  0.15 
Return On Capital Employed 0.19  0.10 
Return On Assets 0.14  0.15 
Return On Equity 0.19  0.10 
Please note, the imprecision that can be found in West Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of West Pharmaceutical Services. Check West Pharmaceutical's Beneish M Score to see the likelihood of West Pharmaceutical's management manipulating its earnings.

West Pharmaceutical Workforce Analysis

Traditionally, organizations such as West Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare West Pharmaceutical within its industry.

West Pharmaceutical Manpower Efficiency

Return on West Pharmaceutical Manpower

Revenue Per Employee278.3K
Revenue Per Executive86.8M
Net Income Per Employee56K
Net Income Per Executive17.5M
Working Capital Per Employee119.3K
Working Capital Per Executive37.2M

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.